2024-27661. Transitional Enforcement Policy for Ethylene Oxide Sterilization Facility Changes for Class III Devices; Guidance for Industry and Food and Drug Administration Staff; Availability  

  • 21 CFR Part; Guidance; or FDA Form Topic OMB control No.
    814, subparts A through E Premarket approval 0910-0231
    814, subpart H Humanitarian Use Devices; Humanitarian Device Exemption 0910-0332
    “Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program” Q-submissions and Early Payor Feedback Request Programs for Medical Devices 0910-0756
    820 Current Good Manufacturing Practice (CGMP); Quality System (QS) Regulation 0910-0073
    807, subparts A through D Electronic Submission of Medical Device Registration and Listing 0910-0625

Document Information

Published:
11/26/2024
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of availability.
Document Number:
2024-27661
Dates:
The announcement of the guidance is published in the Federal Register on November 26, 2024.
Pages:
93297-93299 (3 pages)
Docket Numbers:
Docket No. FDA-2024-D-2274
PDF File:
2024-27661.pdf